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Summary Background. Contact allergy to local anaesthetics is relatively common. Patch testing
with benzocaine in the European baseline series is recommended for diagnosis, even
though a caine mix has been previously suggested to be superior.
Objectives. Toassess the frequencyandpatterns of contact allergy to local anaesthetics
by using a cainemix (benzocaine, tetracaine, and cinchocaine) in the baseline series, and
evaluate its efficiency as compared with benzocaine alone.
Methods. We reviewed the results of 2736 patch tests performed between 2000 and
2010, identifying patients with positive reactions to caine mix or to one of seven local
anaesthetics.
Results. One hundred and twelve patients (4.1%) had at least one allergic reaction
to local anaesthetics; 86 were tested with all seven local anaesthetics, resulting in 71
reactions in 53 patients. Cinchocaine gave the most reactions (50.7%); these occurred
as a single reaction in 83.3% of patients, mostly with current or past relevance (97%).
Benzocaine represented 22.5% of reactions, many of which were non-relevant (44%) or
resulting from cross-reactions with para-compounds.
Conclusions. Almost 70% of allergic reactions to local anaesthetics would have been
missed if benzocaine had been used as a screening allergen. This study supports a
recommendation to replace benzocaine with a caine mix containing cinchocaine in the
baseline patch test series.
Key words: benzocaine; caine mix; cinchocaine; cross-reactions; local anaesthetics;
patch test reactivity.
Local anaesthetics derived from caines are widely used,
mainly in injectable preparations, but also in topical
preparations. Allergic contact dermatitis has frequently
been reported following exposure to creams used for
pruritus ani, haemorrhoids and insect bites, lotions
for sunburn relief, and anaesthetic eye and auricular
drops (1–4). Delayed hypersensitivity to caines used in
local or locoregional anaesthesia is much rarer.
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Caine molecules are structurally divided into three
parts: a lipophilic (aromatic) group, an intermediate chain
linkage, and a hydrophilic (amine) group (5, 6) (Fig. 1).
Depending on their intermediate chain, they are usu-
ally classified into two major groups: esters and amides
(Table 1) (6). Esters, which include benzocaine, procaine,
tetracaine, and amilocaine, are metabolized by plasma
esterases to p-aminobenzoic acid (PABA), which is con-
sideredtoberesponsible for thegreaterallergenicpotential
and cross-reactivity between anaesthetics in this group.
Amide local anaesthetics, which include cinchocaine
or dibucaine, lidocaine, bupivacaine, mepivacaine, and
prilocaine, are notmetabolized into the PABAmetabolite,
and are generally considered to have a lower allergenic
potential (5–12). Within this group, a subdivision into
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Fig. 1. Chemical structure of benzocaine (ester), cinchocaine and
lidocaine (amides).
Table 1. Local anaesthetics used topically or for local anaesthesia
(main synonyms)
Esters Amides
Benzocaine Articaine
Chloroprocaine Bupivacaine
Cocaine Bupivacaine
Procaine Dibucaine/cinchocaine∗
Proparacaine Etidocaine
Tetracaine Levobupivacaine
Lidocaine
Mepivacaine
Prilocaine
Ropivacaine
Sameridine
Tonicaine
∗Considered by some as a separate group, an alkylamide (13).
Adapted from Thyssen et al. (6).
alkylamides (cinchocaine) andacylamides (lidocaine) can
also be considered (13).
At present, benzocaine is recommended within the
European baseline series as a screening allergen to
show contact allergy to local anaesthetics. Nevertheless,
its efficacy has been repeatedly questioned since the
1980s (11, 14, 15). Several suggestions to use a caine
mix (as used in the TRUE Test (10) have not been fully
accepted (11, 16), although this is the current practice in
some countries, such as Portugal. Our studywas aimed at
clarifying the superiority of patch testingwith a cainemix
in the European baseline series, which includes two ester
local anaesthetics and one amide local anaesthetic, over
patch testing with the ester local anaesthetic benzocaine
alone.
Material and Methods
Between 1 January 2000 and 31 December 2010,
we sequentially patch tested 2736 patients with a
mean age of 43.9± 16 years (M, 29.5%; O, 23.5%;
A, 24.3%; H, 37.9%; L, 6.8%; F, 26.1%; A, 52.4%). They
underwent patch testing with the Portuguese baseline
series, a modified European baseline series that includes
a caine mix at 10% in petrolatum (benzocaine 5%
pet., tetracaine 2.5% pet., and cinchocaine 2.5% pet.;
Chemotechnique Diagnostics, Vellinge, Sweden) instead
of benzocaine.
Forty-six patients with a clinical history of contact
dermatitis who might have used local anaesthetics,
mainly with anogenital dermatitis or in an occupational
setting, and 4 patients previously studied in the allergy
department because of a localized oedema of the oral
mucosa within 24 hr of a consultation with a dentist
and who had negative test results, were simultaneously
patch tested, on their first visit, with a series of local
anaesthetics that included benzocaine 5% pet., tetracaine
5% pet., procaine 1% pet., amilocaine 5% pet., lidocaine
5% pet., cinchocaine 5% pet., and prilocaine 5% pet.
(Chemotechnique Diagnostics). All caine mix-positive
patients were offered further testing with the same series
of local anaesthetics.
Patch tests were applied on the upper back for 2 days
with FinnChambers on Scanpor tape (Epitest Ltd., Oy,
Finland). Readings were performed at D2 and D3 or D4,
according to International Contact Dermatitis Research
Group guidelines (17), with advice for a referral reading
at D7 in case of a late reaction.
Patients with positive reactions (1+ or more intense)
to the caine mix or to any of the separate allergens
were evaluated with regard to age, sex, dermatosis
location, positive reactions to chemicals of the para-group
tested in the baseline series, namely p-phenylenediamine
(PPD), N -isopropyl-N ′-phenyl-p-phenylenediamine and
parabens, and relevance of positive reactions based on
medical history.
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Table 2. Prevalence of positive reactions to local anaesthetics, with a total number of 71 positive reactions occurring in 53 patients
Number of positive reactions (n = 71) One positive reaction (n = 41, 77.4%) ≥2 positive reactions (n = 12, 22.6%)
n % (n/ntotal) n % (n/ntotal) n % (n/ntotal)
Cinchocaine 36 50.7 30 56.6 6 11.3
Benzocaine 16 22.5 7 13.2 9 17
Tetracaine 8 11.3 1 1.9 7 13.2
Procaine 6 8.4 1 1.9 5 9.4
Lidocaine 3 4.2 1 1.9 2 3.8
Amilocaine 2 2.8 1 1.9 0 0
Prilocaine 0 — 0 0 0 0
Results
Of the 2736 patients, 110 reacted to the caine mix in the
baseline series (4.0%), and2additional patients reacted to
cinchocaine during aimed testing. In total, 112 patients
(35 males and 77 females, mean age 49.7± 15.1 years)
had at least one allergic reaction to local anaesthetics,
representing 4.1% of the whole population.
Of these patients, only 86 (25 males and 61 females,
mean age 49.3± 15.1 years) were patch tested with
all seven separate local anaesthetics; 84 reacted to the
caine mix, and 2 were caine mix-negative but reacted to
cinchocaine.
In 39.3% of caine mix-positive patients, local anaes-
thetics tested separately gave negative results, in 52%
of those with a 1+ reaction and 48% with a 2+
or 3+ reaction. Fifty-three patients (15 males and
38 females, mean age 51.1± 15.3 years) had posi-
tive patch test reactions to separate local anaesthetics
(61.6%). Forty-one (77.4%) reacted only to one local
anaesthetic, and 12 (22.6%) had two or more positive
reactions, corresponding to a total of 71 positive reactions
(Table 2).
Reactions to cinchocaine were most common (36/71,
50.7%), followed by reactions to benzocaine (16/71,
22.5%), tetracaine, procaine, lidocaine, amilocaine, and
prilocaine (Table 2). Most reactions to cinchocaine were
isolated (30/36, 83.3%), whereas more than half of
benzocaine-reactive patients (9/16), 7 of 8 of tetracaine-
reactive patients and 5 of 6 of procaine-reactive patients
showed reactivity to other local anaesthetics (Table 2).
Concerning reactivity to the different chemical groups
(Tables 3 and 4), 14 patients reacted only to esters
(26.4%), 31 only to amides (58.5%), and 8 to both groups
(15.1%) (Table 5).
Reactivity to chemicals of the para-group (Table 6)
was observed in 8 of 53 patients (15.1%), 7 of
them with reactivity to benzocaine and/or other ester
local anaesthetics. One patient with contact dermatitis
caused by a temporary henna tattoo also reacted to
an amide local anaesthetic, cinchocaine. One patient
with anogenital dermatitis caused by cinchocaine in an
Table 3. Reactivity only to ester local anaesthetics
Reactivity to esters only (n = 14)
Age (years) Sex Benzocaine Tetracaine Procaine Amilocaine Relevance Presentation
1 54 F + – + NA Cross-reaction Eyelids
2 20 F + + + NA Cross-reaction Face
3 56 F + – – NA Past Lips
4 22 F + – – – No Eyelids
5 72 F + + – NA Past Leg ulcer
6 27 F + – – NA No Generalized
7 49 M + – – – Past Trunk
8 47 F – + – – Past Hand
9 40 F + – – – Cross-reaction Hand
10 53 F + – + – Past Extremity
11 78 F – – + – Cross-reaction Eyelids
12 51 F + – – – Past Generalized
13 52 F – – – + Past Eyelids
14 14 F + – – – Cross-reaction Tattoo
+, positive; – , negative; F, female; M, male; NA, not applicable.
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Table 4. Reactivity only to amide local anaesthetics
Reactivity to amides only (n = 31)
Age (years) Sex Lidocaine Cinchocaine Prilocaine Relevance Presentation
1 52 F – + NA Current Anogenital
2 51 M – + – Current Anogenital
3 65 M – + – Past Hand
4 49 M – + – Current Anogenital
5 25 F – + – Past Hand
6 72 F – + – Current Anogenital
7 58 F – + – Current Anogenital
8 53 F – + – Past Immediate HS
9 51 M – + – Current Anogenital
10 60 F – + – Current Anogenital
11 42 M – + – Past Hand
12 59 F – + – Past Lips
13 72 F – + – Past Trunk
14 62 F – + – Past Immediate HS
15 35 F + – NA No Lips
16 36 F – + – Past Immediate HS
17 57 F – + – Current Anogenital
18 54 F – + – Current Anogenital
19 73 F – + – Past Eyelid
20 32 M – + – Current Anogenital
21 56 F – + – Past Immediate HS
22 77 F – + – Past Generalized
23 60 M – + – Past Generalized
24 43 M – + – Current Anogenital
25 44 F – + – Current Eyelids
26 73 F – + – Past Leg
27 57 M – + – Current Anogenital
28 50 M – + – Current Anogenital
29 66 F – + – Past Penicillin HS
30 45 F – + – Past Penicillin HS
31 28 F – + – Past Hand
+, positive; – , negative; F, female; HS, hypersensitivity; M, male; NA, not applicable.
Table 5. Reactivity to both ester and amide local anaesthetics
Reactivity to both esters and amides (n = 8)
Ester Amide
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Relevance Presentation
1 – + – NA – + NA Past Hand
2 – + – NA – + NA Current Anogenital
3 + + + NA – + NA Cross-reaction Tattoo
4 + – – – + – – Past Face
5 + + + + + NA NA Past Generalized
6 + – – – – + – Current Anogenital
7 – + – – – + – Current Anogenital
8 + – – – – + – Current Generalized
+, positive; – , negative; NA, not applicable.
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Table 6. Cross-reactivity between local anaesthetics and para-group compounds
Cross-reactivity between local anaesthetics and para-group compounds (n = 8)
Ester Amide Para group
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Relevance Presentation
1 + – + NA – – NA + – – Cross-reaction Eyelids
2 + + + NA – – NA + – – Cross-reaction Face
3 + + + NA – + NA + + – Cross-reaction Tattoo
4 + – – – – NA – + – – Cross-reaction Hand
5 + – + – – NA – + – – Past Leg
6 – – + – – – – + – – Cross-reaction Eyelid
7 + – – – – – – + – + Cross-reaction Tattoo
8 – – – NA – + NA + – – Current Anogenital
+, positive; – , negative; IPPD, N-isopropyl-N′-phenyl-p-phenylenediamine; NA, not applicable; PPD, p-phenylenediamine.
anti-haemorrhoid ointment had a positive PPD allergy, a
probable concomitant reactionwith relevance toprevious
hair dye allergy.
Among the 53 patients with positive reactions to at
least one anaesthetic, 44 (83%) were considered to be
relevant, 19 (35.8%) of which with current relevance.
Anogenitaldermatitiswas theprimarysiteof involvement
in 16 patients (30.2%). Previous exposure to local
anaesthetics with past relevance was considered in 25
patients (47.2%)whowere patch tested for other reasons,
mainly because of hand eczema.
On comparison of the relevance of cinchocaine
and benzocaine reactions, 35 of cinchocaine reactions
(97.2%) were relevant, whereas relevance could be
suspected in only 9 of 16 benzocaine-allergic patients
(56.2%), with many reactions being explained by cross-
reactivity with PPD in henna tattoos or hair dye
allergy (3).
In the group of 53 patients with allergy to at least
one anaesthetic, 37 did not react to benzocaine (69.8%).
Thus, contact allergy to local anaestheticswouldnothave
been diagnosed or suspected if benzocaine were the only
anaesthetic tested in the baseline series, whereas only 2
of 112 patients would have been missed with use of the
caine mix (1.8%).
Discussion
The 4.0%prevalence of cainemix reactivity reported here
is higher than in other studies, namely those of Beck and
Holden (11), with 84 of 3000 patients positive (2.8%)
and Sidhu et al. (16), with 91 of 5464 patients positive
(1.7%), both using the same caine mix, and Wilkinson
et al. (18),with26of 1981patients positive (1.3%), using
a caine mix with higher concentrations (15% and 25%).
Cinchocaine (dibucaine), which is included in the
amide group that is considered to be less allergenic,
was the main agent responsible for contact allergy to
local anaesthetics, and so it seems to be very useful for
screening for contact allergy to local anaesthetics. This
is in line with recent studies in the United Kingdom and
Finland (16, 18, 19), but in contrast to older reports,
where benzocaine reactivitywasmost prevalent (11, 20),
namely in the United Kingdom, where it represented
47.5% of positive reactions to local anaesthetics by the
endof the1980s (11).Availabilityandprescriptionhabits
are different between countries and are continuously
changing over time,whichmay explain the high variabil-
ity of results across the world. The anti-haemorrhoid
topical treatments that are frequently used contain
mainly cinchocaine, as the over-the-counter ointments
Faktu and Nupercainal, and Scheriproct ointment,
which requires a medical prescription. Others contain
tetracaine (Hemofissural or lidocaine (Doxiproct and
Ultraproct. Two patients presented with a generalized
dermatitis caused by cinchocaine, probably related to sys-
temic absorption through the rectal mucosa, as reported
elsewhere (21, 22).
Over 75% of patients reacted to a single local
anaesthetic, in accordance with other studies (11, 20).
Of the patients reacting to multiple local anaesthetics,
66.7% reacted to both esters and amides, which is a lower
proportion than in Warshaw’s study (20). Within the
ester group, reactivity to two or three local anaesthetics
could be explained by cross-reactivity, owing to the
chemical similarity of these molecules. Within the amide
group, as in other reports, no simultaneous reactions
were observed between cinchocaine and lidocaine (13,
23, 24), and cinchocaine-positive patients tolerated local
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anaesthesia with subcutaneous lidocaine, which may
suggest that cinchocaine should be included in a sepa-
rate subgroup within the amide local anaesthetics, as an
alkylamide (13).
Simultaneous reactivity to cinchocaine or lidocaine
and an ester-type local anaesthetic, similar to that pre-
viously reported (15, 19), may be a result of separate
sensitization, because most of those patients have been
exposed to multiple topical drugs. In 3 patients, we could
not explain the simultaneous reactivity to ester andamide
local anaesthetics.
Probable cross-reactivity between local anaesthetics
and other chemicals with a para-group occurred in
8 patients,mainlywithin thegroupof benzocaine-allergic
patients (37.5%), in accordance with the 33% of cases
reported by Thyssen et al. (14). In contrast, only 5.6%
of cinchocaine-allergic patients showed reaction to these
chemicals.
Benzocaine was once regarded as a good indicator of
local anaesthetic sensitization. Nowadays, however, it is
rarely used by pharmaceutical companies, whereas cin-
chocaine is present in many over-the-counter anogenital
preparations. Benzocaine induced positive reactions in a
minority of patients (18.6%), 44% of which were either
not relevantorattributable to cross-reactions, suggesting,
as in the study of Thyssen, that this allergen is not useful
in the baseline series (14). In contrast, cinchocaine, the
main allergen responsible for caine mix reactivity, was
considered tobe relevant in97.2%of cases,mainly related
to anti-haemorrhoid ointments. Adding cinchocaine to
benzocaine in a mix allowed the diagnosis of contact
allergy to local anesthetics in 37 additional patients,most
of them with relevant reactions (94.6%).
The caine mix used did not detect 2 patients with
relevant reactions to cinchocaine probably because cin-
chocaine is tested separately at a higher concentration
(5% pet). Approximately 40% of caine mix-positive
patients did not react to its constituents, which might
suggest false-positive reactions, even though two were
still considered to be relevant. We suggest that, after a
caine mix positive reaction, it is highly recommended to
test caines separately before advising patients concerning
avoidance of local anaesthetics.
Thepresent study,withasignificantnumberofpatients
from a single centre, has the limitation that caine mix
and benzocaine were not simultaneously tested in all
patients. Nevertheless, these data have shown that the
caine mix detected significantly more cases of relevant
contact allergy to local anaesthetics than benzocaine.
Some of these were unsuspected from the clinical history,
and would have been missed if benzocaine was tested
alone in the baseline series. Accordingly, a caine mix
containing cinchocaine could, with benefit, replace ben-
zocaine in the European baseline series, but amulticentre
study involving several clinics in Europe simultaneously
patch testing caine mix and benzocaine could strongly
contribute to a definite recommendation to change the
baseline series.
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